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Abstract: Synucleins (syns) are a family of proteins involved in several human 
neurodegenerative diseases and tumors. Since the first syn discovery in the brain of the 
electric ray Torpedo californica, members of the same family have been identified in all 
vertebrates and comparative studies have indicated that syn proteins are evolutionary 
conserved. No counterparts of syns were found in invertebrates suggesting that they are 
vertebrate-specific proteins. Molecular studies showed that the number of syn members 
varies among vertebrates. Three genes encode for α-, β- and γ-syn in mammals and birds. 
However, a variable number of syn genes and encoded proteins is expressed or predicted in 
fish depending on the species. Among biologically verified sequences, four syn genes were 
identified in fugu, encoding for α, β and two γ (γ1 and γ2) isoforms, whereas only three 
genes are expressed in zebrafish, which lacks α-syn gene. The list of “non verified” 
sequences is much longer and is often found in sequence databases. In this review we 
provide an overview of published papers and known syn sequences in agnathans and fish 
that are likely to impact future studies in this field. Indeed, fish models may play a key role 
in elucidating some of the molecular mechanisms involved in physiological and 
pathological functions of syn proteins. 
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1. From Fish to Human: The Discovery of the Synuclein Family 
Fish played a key role in the studies in the 1980’s that led to the discovery of the first synuclein 
(syn) sequence. In 1980, Carlson and Kelly [1] produced a rabbit antiserum against highly purified 
synaptic vesicles from the electric organ of the ray Narcine brasiliensis. Afterwards, in 1988, 
Maroteaux and co-workers [2] used the same antiserum to screen a cDNA library constructed with 
mRNA isolated from the brain electromotor lobe of Torpedo californica. One gene was characterized 
and sequenced having a transcript of about 1.4 kb and encoding a protein with a predicted molecular 
weight of 14.811 Da whose expression was restricted to the central nervous system (CNS). This new 
protein was named “synuclein” for its predominant localization in both presynaptic terminals and 
neuronal nucleus. Western blot experiments performed with an antiserum against a Torpedo syn/B-gal 
fusion protein detected three protein bands at 17.5, 18.5 and 20.0 kDa in CNS homogenates from 
Torpedo. The authors concluded that syn was a protein or a series of proteins specifically expressed in 
the CNS and possibly involved in the coordination of nuclear and synaptic events. In the same work, 
Maroteaux and coworkers found a homolog to Torpedo syn in the rat brain cDNA library. Sequence 
analysis revealed about 85% identity between fish and rat syns, suggesting that the new protein is 
conserved among vertebrate lineages. 
In 1993, a homologous protein to rat syn was discovered in the brain of patients affected by 
Alzheimer’s disease (AD) [3]. While studying the composition of the amyloid plaques, Ueda and  
co-workers [3] were able to solubilize a previously unknown peptide that was named NAC (non-aβ 
component of AD amyloid). Its precursor, namely NAC protein (NACP), was homologous to rat syn. 
In the same years, the phosphoneuroprotein 14 (PNP 14), initially identified in bovine brain, was 
determined to be an additional member of the syn family [4–6]. NACP and the human ortholog of PNP 
14 were then identified as two distinct isoforms of the syn family and respectively named α- and  
β-syn [7]. A third variant, structurally homologous to Torpedo syn was added to α- and β-syn: this 
protein was identified in both human [8] and rat [9] and named γ-syn [10]. 
Human α-, β- and γ-syn are encoded by three distinct genes, snca, sncb and sncg respectively. The 
three genes map to different chromosomes (4q21.3-q22, 5q35 and 10q23) [10–15] and have a well 
preserved general organization made by five coding exons of similar size [16]. Alpha- and β-syn are 
predominantly expressed in the brain, particularly in neocortex, hippocampus, striatum, thalamus,  
and cerebellum whereas γ-syn is mainly expressed in the peripheral and the autonomic nervous  
system (cell bodies and axons of primary sensory, motor and sympathetic neurons) and in some  
tumors [8,10,17–21]. 
After the discovery of the three syns, research was primarily focused on α-syn for its involvement in 
several human neurodegenerative diseases known as synucleinopathies including Parkinson’s disease 
(PD), Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB), multiple system 
atrophy (MSA), and a number of less well-characterized neuroaxonal dystrophies [22–28]. 
The universal feature of synucleinopathies is the accumulation of intracellular proteinaceous bodies 
containing α-syn aggregates rich in β-sheets [24]. These aggregates are called Lewy bodies in PD  
and PDD [29], glial cytoplasmic inclusions in MSA [30] and axonal spheroids in neuroaxonal 
dystrophies [31]. There is evidence indicating that molecular mechanisms involved in the pathogenesis 
of synucleinopathies are the misfolding of α-syn proteins into aggregates and their accumulation into 
Mar. Drugs 2015, 13 6667 
 
 
intracellular bodies [29], and that neurotoxicity and cell death arise as a consequence of the dramatic 
α-syn accumulation [32,33]. 
Among synucleinopathies, the role of α-syn has been more widely investigated in PD. Single 
nucleotide polymorphisms in snca are strongly associated with the increased risk for idiopathic  
PD [34–37]. The snca missense mutation A53T was the first causal mutation identified in dominantly 
inherited PD [38]; other snca missense mutations such as A30P [39], E46K [40], H50Q [41,42],  
G51D [43], A53E [44] were then detected. In vitro experiments demonstrated that snca missense 
mutations accelerate the formation of α-syn fibrils [45]. Furthermore, snca duplications [46,47] and 
triplications [48] also lead to familiar PD suggesting that excessive amounts of normal proteins also 
cause PD. In addition, the formation of pathological inclusions may be promoted by α-syn  
post-translational modifications such as ubiquitination, nitration and phosphorylation [49–51]. 
Twenty-five years of research on syn-linked pathologies provided little advance in the discovery of 
physiological functions of syn proteins that still remain elusive. The collected body of evidence 
indicates that α-syn functions are related to its capacity to directly interact with membrane 
phospholipids by the highly conserved α-helical lipid-binding motif in the N-terminal region [52]. In 
particular, α-syn has been implicated in vesicle trafficking during neurotransmitter release [53,54], 
synaptic vesicle pool maintenance [55,56], synaptic plasticity [40] and learning [57]. Differently,  
γ-syn, first identified as breast cancer specific gene 1 (BCSG1) [8], is involved in tumor pathogenesis 
and correlates with adverse outcomes in breast [8,17], colon [18,19], pancreatic [20] and ovarian 
cancer [17]. Studies have revealed that the γ-syn overexpression leads to increased invasiveness of 
breast tumor cells [58] and stimulates cell proliferation [59]. 
Despite most research was focused on mammalian models, some advances were also made on syn 
expression in non-mammalian vertebrates. After Maroteaux’s pioneering work, α-syn-coding mRNAs 
were sequenced in representative fish, amphibians, reptiles, birds and non-primate mammals. The 
comparison of deduced amino acid sequences revealed that α-syns are evolutionary conserved in 
vertebrates [60–62]. Moreover, syn proteins are thought to exist only in vertebrates since no 
counterparts of their genes were found in the invertebrates investigated so far, i.e., Caenorhabditis 
elegans, Drosophila melanogaster and Ciona intestinalis [63]. Recently, one α-syn sequence has been 
unexpectedly predicted from the genome of the tobacco Nicotiana tomentosiformis (XP_009616054.1 
NCBI database). The mRNA coding sequence of the putative plant α-syn shares 100% of identity with 
that of human α-syn (transcript variants 1, 2, 3 and 6) and no homologous sequence is present in 
maize, rice and the Arabidopsis genome. Given the full identity between human and Nicotiana syn 
sequences, it can be assumed that the predicted tobacco syn represents a human contaminant of the 
plant cDNA library or a mislabeling of the sequence in NCBI. However, syn expression needs to be 
analyzed in tobacco cells before ruling out the putative existence of syn-like proteins in plants. 
Current data on fish syns can be grouped in two sets: results from in vivo studies and putative 
nucleotide and amino acid sequences from biological databases, that were not verified in animal 
models. Although published papers are quite scarce, notable advancements have been made in 
zebrafish and carp, two ciprinids known as species models for vertebrates. Moreover, the list of 
putative syn sequences is continuously implemented, and we believe that an overview of available data 
is likely to stimulate research on the evolution of syn proteins in fish lineages. On the other hand, 
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increasing knowledge about fish syns is helpful to develop new vertebrate models of parkinsonism for 
investigating relationships between syn proteins and neurodegenerative diseases. 
In the present review, we provide a systematic framework for the available syn sequences of 
agnathans and fish. The same sequences were also compared by the maximum likelihood approach to 
get a first insight into the evolution of this gene family in fish. We also review the experimental studies 
recently performed in lamprey, fugu, zebrafish and carp. 
2. Syn Isoforms in Agnathans and Fishes 
Up to 144 nucleotide or deduced amino acid sequences of fish syns are available in the NCBI 
database (July 2015) from 29 species including jawless, cartilagineous and bony fishes. Most of them 
were obtained by RT-PCR of mRNAs extracted from blood or other tissues or predicted by 
computational analysis of the whole genome expression. Available sequences are summarized in  
Table 1. The following orders are represented: Petromyzontiformes (3 sequences), Chimaeriformes (7), 
Torpediniformes (1), Acipenseriformes (1), Lepisosteiformes (2), Osteoglossiformes (1), Cypriniformes (10), 
Characiformes (6), Siluriformes (1), Osmeriformes (1), Salmoniformes (8), Esociformes (14), 
Beloniformes (8), Cyprinodontiformes (16), Scorpaeniformes (1), Perciformes (43), Pleuronectiformes 
(7), Tetraodontiformes (11), and Coelacanthiformes (3). Twenty-five of the 29 species are ray-finned 
fishes and 23 of them are teleosts, belonging to the subdivisions Osteoglossomorpha (1 species), 
Ostarioclupeomorpha (4 species) and Euteleostei (18 species), the first two displaying more primitive 
morphological characters than Euteleostei. This last subdivision comprises the largest percentage of 
extant teleosts (94%, about 17,000 species, 346 families) [64,65]. Two more ray-finned fishes are one 
chondrostean and one lepisostean. The remnant four species include the lamprey, two cartilagineous 
fishes and one sarcopterigian. Although the picture is far from being complete, some speculations can 
be made on the evolutionary diversification of syns in fishes. 
Three different syn sequences have been described in the lamprey Petromyzon marinus [66]. On the 
basis of the percentage of similarity with human syns the authors classified two of them as γ-syn DY 
(JN544525.1) and γ-syn FD (JN544526.1) whereas the third sequence was named “lamprey synuclein 3” 
(JN544527.1) as the percentage of identity between this protein and human syns did not allow any 
reliable classification. 
After the discovery of Torpedo syn, the first study aimed at identifying the number of syn genes in 
the ray-finned fishes was performed in the pufferfish Takifugu rupribes [61]. In this tetraodontid,  
Yoshida and co-workers recognized four different genes that were assigned to α-(snca), β-(sncb),  
γ1- (sncga = sncg1) and γ2-syn (sncgb = sncg2). Each syn gene in fugu contains five coding exons 
showing similar size and organization to human syn genes. Interestingly, T. rubribes was the first 
species in which four genes were identified, as all vertebrates until then investigated showed three syn 
genes, likewise mammals [61,67]. 
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Table 1. Amino acid sequences of fish synucleins including agnathans, chondrichthyans and osteichthyans available at the NCBI protein 
database (http://www.ncbi.nlm.nih.gov/protein). For each species the class, subclass, order and family are indicated (according to [65]). 
Sequences are divided in α-syn, β-syn, γ-syn and synuclein/synuclein-like (when the classification was not given). Bold numbers refer to the 
percentage of identity with human α-, β- and γ-syns and numbers in superscript refer to syn sequences reported in the Supplemental Data. The 
sequences in the same box of the table refer to identical amino acid sequences. Sequences highlighted in green, blue and red indicate X1, X2 
and X3 isoforms, respectively. Dark gray, gray and light gray refer to species belonging to the subdivisions Osteoglossomorpha, 
Ostarioclupeomorpha and Euteleostei, respectively. Asterisks indicate the partial sequences. 
Class Subclass Order Family Species Alpha synuclein  (identity with human α-syn) 
Beta synuclein  
(identity with human β-syn)
Gamma synuclein  
(identity with human γ-syn)
Synuclein-like  
(identity with human α-syn) 
Petromyzontida Petromyzontiformes Petromyzontidae Petromyzon marinus
 
67%1 53%2 52%3
 
Chondrichthyes
Holocephali Chimaeriformes Callorhinchidae Callorhinchus milii 74%4,5
 
78%6–8 61%9 54%10
 
Elasmobranchii Torpediniformes Torpedinidae Torpedo californica
 
59%11
 
Actinopterygii
Chondrostei Acipenseriformes Acipenseridae Acipenser sturio 94%12*
   
Neopterygii Lepisosteiformes Lepisosteidae Lepisosteus oculatus
 
82%13 61%14
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Osteoglossiformes Osteoglossidae Scleropages formosus
 
50%15
 
Cypriniformes Cyprinidae 
Cyprinus carpio 99%16*
   
Danio rerio 
 
71%17–20 50%21–23 52%24,25
 
Characiformes Characidae Astyanax mexicanus 55%26
 
35%27 60%28 53%29 28%30 52%31 
Siluriformes Siluridae Silurus glanis 99%32*
   
Osmeriformes Osmeridae Osmerus mordax 68%33
Salmoniformes Salmonidae Salmo salar 
 
51%34,35 50%36,37 54%38 53%39,40 43%41
 
Esociformes Esocidae Esox lucius 52%42–44 46%45 51%46 56%47,48 56%49 55%50 54%51 58%52 53%53,54 43%55
 
Beloniformes Adrianichthyidae Oryzias latipes 61%56,57 57%58
 
59%59,60 49%61 50%62 55%63
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Table 1. Cont. 
  
Cyprinodontiformes Poeciliidae 
Poecilia formosa 62%64 46%65
 
61%66 55%67 46%68
   
Poecilia reticulata 62%69 46%70
 
62%71 55%72 46%73
   
Xiphophorus maculatus 62%74
 
61%75,76 56%77 55%78 50%79 
 
Scorpaeniformes Anoplopomatidae Anoplopoma fimbria 
 
59%80
   
Perciformes 
Cichlidae 
Astatotilapia burtoni 61%81 52%82 60%83 
 
61%84,85 56%86
   
Maylandia zebra 61%87
 
61%88,89 55%90 53%91 57%92
   
Neolamprologus brichardi 48%93 61%94
 
61%95,96 57%97
   
Oreochromis niloticus 60%98 57%99 52%100 60%101 61%102 61%103
   
Pundamilia nyererei 61%104 52%105 60%106 
 
61%107,108 57%109
   
Pomacentridae Stegastes partitus 50%110 54%111
 
61%112 51%113 50%114 50%115 56%116 
Nototheniidae Notothenia coriceps 43%117 58%118
 
58%119
   
Sciaenidae Larimichthys crocea 61%120
 
62%121 53%122 57%123
   
Pleuronectiformes Cynoglossidae Cynoglossus semilaevis 54%124,125
 
60%126 50%127 51%128 50%129 55%130
   
Tetraodontiformes Tetraodontidae Takifugu rubripes 61%131,132 61%133
 
60%134–136 55%137,138 52%129,140 52%141
   
Sarcopterygii Coelacanthimorpha Coelacanthiformes Latimeriidae Latimeria chalumnae 83%142
 
86%143 60%144
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The presence of one additional syn gene in fugu was attributed to the whole genome duplication 
that occurred about 230 million years ago in the ray-finned fishes (Osteichthyes, Actinopterygii) which 
was followed by the subsequent loss of some duplicated genes [68,69]. On the basis of this 
assumption, a major variability in the number of syn isoforms can be expected in teleosts caused by 
events of gene duplication/loss. 
A clear example of this variability is represented by zebrafish (Danio rerio) in which three genes 
were identified, sncb (coding for β-syn), sncga (γ1) and sncgb (γ2) [70–72], none of which coded for 
α-syn. Indeed, the zebrafish genome lacks snca. This absence has been explained by the putative loss 
of the ancestral snca, together with its flanking sequences, during zebrafish evolution [71]. The same 
studies demonstrated that zebrafish sncb and sncga give rise to single mRNA species of 1.45 kb and 
2.7 kb respectively, whereas sncgb is alternatively spliced to produce two transcripts encoding two 
isoforms with divergent C-terminals. Both sncga and sncgb contain five exons whereas sncb contains 
six exons, the first of which is noncoding. Gene structure and splice boundaries in sncb, sncga, and 
sncgb are conserved with respect to their human orthologs, providing evidence of their common origin. 
At least one coding sequence for α-syn was predicted in the other fish except from Lepisosteus 
ocellatus, Scleropages formosus, Osmerus mordax, Salmo salar and Anoplopoma fimbri (Table 1). In 
most of them, one or more β- and γ-syn sequences were also identified. 
The absence of α-syn sequences from genebank could be theoretically attributed to the absence of 
snca in respective fish genomes. If confirmed, this would suggest that the α-syn coding gene had been 
independently lost in distinct actinopterygian fish lineages. At the moment, however, available data 
cannot be interpreted in this way, as the presence of α-syn sequences was not specifically investigated 
in all species. Data are still scarce. Moreover, some sequences have not been classified yet as α, β- or 
γ-syn, being simply reported as “syn” or “syn-like” isoforms. In addition, almost all the encoded or 
predicted proteins were not isolated nor characterized and several accession numbers refer to gene 
sequences encoding the same protein. 
Additional isoforms named X1, X2 or X3 are present among α-, β-, and γ-syns. The denomination 
“X1, X2 and X3” refers to the name reported in the NCBI database and no physiological relevance 
may be currently assigned to this nomenclature. X1 and X2 α-syn isoforms have been sequenced in the 
esocid Esox lucius and cichlids Astatotilapia burtoni, Oreochromis niloticus and Pundamilia nyererei. 
Only X1 or X2 α-syn sequences are available in T. rubripes, and the pomacentrid Stegastes partitus, 
respectively. Moreover, X3 α-syn isoform has been sequenced in poecilids, Poecilia formosa and 
Poecilia reticulata. 
X1 and X2 β-syn isoforms have been sequenced in E. lucius, the poecilid Xiphophorus maculates, 
cichlid Astatotilapia maculatus, cichlids A. burtoni, Neolamprologus brichardi, O. niloticus and  
P. nyererei. Only X1 β-syn sequences are available in T. rubripes. Moreover, X1, X2 or X3 γ-syn 
isoforms have been sequenced in the osteoglossid Scleropages formosus (X2), in E. lucius (X1 and 
X2), in the adrianichthyd Oryzias latipes (X1, X2 and X3), in P. formosa and P. reticulata (X1), in the 
cichlid Maylandia zebra (X1 and X2), in the cynoglossid Cynoglossus semilaevis (X1 and X2), and in 
T. rubripes (X1). 
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Finally, among sequences classified as “syn” or “syn-like”, X1, X2, X3 isoforms have been 
sequenced in the characid Astyanax mexicanus (X1, X2, X3), in X. maculatus (X1, X2), in S. partitus 
(X1, X2) and in C. semilaevis (X1, X2). 
Predicted fish syns are small proteins of 95–230 aa with a molecular weight (MW) ranging from 
10,204 Da to 24,219 Da. Currently known α-syns correspond to proteins ranging from 102 aa 
(XP_010862493, E. lucius) to 224 aa (XP_008435281.1, P. reticulata) with a predicted MW of  
10,204 and 23,439 Da, respectively. The 222 aa long protein XP_007562501.1 expressed in  
P. formosa showed, among fish α-syns, the highest MW of 23,458 Da. Fish β-syns are proteins with a 
length ranging from 115 aa (ACM08255.1 and ACI68037.1 of S. salar, XP_010898460.1 of E. lucius) 
to 150 aa (XP_007904439.1, Callorhinchus milii) with a predicted MW of 12,030 Da, 12,124 Da, 
11,971 Da and 15,636 Da, respectively. Fish γ-syns range from 95 aa (XP_007234673.1, A. mexicanus) to 
381 aa (KKX05474.1, S. formosus) that correspond to a predicted MW of 10,262 Da and 39,353 Da, 
respectively. The sequences named generally as “syn” or “syn-like” proteins consist of a number of 
amino acids ranging from 103 (XP_007240046.1, A. mexicanus) to 137 (AEO50950.1, P. marinus) 
corresponding to a MW of 10,548 and 14,244 Da, respectively. 
Predicted fish syns are generally acidic proteins with an isoelectric point (pI) ranging from 4.31 to 
7.75. α-syns showed a predicted pI from 4.35 (XP_010862484; E. lucius) to 6.20 (XP_010775984.1, 
Notothenia coriiceps); β-syns from 4.31 (ACM08255.1, S. salar and NP_001029018.1, T. rubripes) to 
4.48 (XP_006631988.1, L. ocellatus), and γ- syns from 4.39 (NP_001029017.1, T. rubripes) to 7.75 
(XP_007234673.1, A. mexicanus). The sequences generally named “syn” or “syn-like” proteins 
showed a predicted pI from 4.35 (XP_008297681.1, S. partitus) to 5.54 (XP_005943970.1, A. burtoni). 
The comparison between fish and human syn sequences showed that fish syns share a percentage of 
identity from 28% to 99% with their human orthologs (Table 1). Sequence identity varies from 43% to 
99% for α-syns, from 50% to 86% for β-syns and from 35% to 67% for γ-syns. 
With the aim of classifying available fish syns, we have analyzed the 144 aa sequences reported in 
Table 1 by Clustal W2, ProtTest 2.4 server (http://darwin.uvigo.es/software/prottest2_server.html) and 
MEGA 6.02 software and obtained the maximum likelihood tree represented in Figure 1.  
As shown, there is a good separation between α- and β-syns. Only five α-syn sequences clustered 
together with human and rat α-syns (α-syn C1). The remaining α-syns showed a lower degree of 
identity with the mammalian isoforms clustering in two main distant groups (α-syn C2 and C3). The  
α-syn C2 and C3 are composed of 19 and 9 sequences respectively. The α-syn C2 contains mainly the 
so-called “α-syn-like” sequences whereas α-syn C3 contains mainly X1 and X2 α-syn isoforms. The 
remaining 9 α-syn sequences clustered with “syn-like” proteins and γ-syns.  
The 26 fish β-syn sequences showed a good level of identity with human β-syn, grouping in the 
cluster β-syn C1. 
Gamma-syns are widely distributed in the cladogram forming two main groups (γ-syn C1 and C2). 
γ-syn C1 contains fish γ-syns with the highest identity to mammalian γ-isoforms. Interestingly, γ-syns 
from P. marinus and T. californica were located in this cluster. The cluster γ-syn C2 contains mainly 
the X1, X2, and X3 γ-syn isoforms. The remaining γ-syn are distributed in the cladogram clustering 
mainly with X1, X2 and X3 isoform of α-syns and syn-like sequences. Moreover, nine “syn-like” 
sequences clustered together in the sl group. 
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Figure 1. Cladogram of a ClustalX2 alignment of the ammino acid sequence of fish syns 
available in the NCBI database and reported in Table 1. The syn isoforms (a = α-syn;  
α-syn (C1) 
γ-syn (C2) 
α-syn (C3) 
α-syn (C2) 
γ-syn (C1) 
sl 
β-syn (C1) 
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b = β-syn; g = γ-syn; s = synuclein, sl = synuclein like) with their accession numbers are 
shown on the right of the tree. The distance matrix employed maximum likelihood with 
bootstrapping (500 repetitions). Sequences highlighted in gray, orange, light blue, green 
and yellow refers to α-syns, β-syns, γ-syns, syn and syn-like, respectively. Arrows indicate 
human and rat sequences. Main sequence clusters (C) are indicated on the right of the figure.
The cladogram shows that most α-syn isoforms previously classified as α-syn-like or X1, X2 and 
X3 showed major affinity for γ-syn isoforms, whereas X1 and X2 β-syn have high identity percentage 
with mammalian β-syn. 
This comparative analysis indicated that the assignment of syn sequences to α-, β- or γ-syn group is 
not reliable until detailed sequence information will be available. Sequence data thus needs to be 
implemented in more fish groups and better characterized in order to give a clear framework on how 
syn proteins evolved in fish lineages. 
3. Gene Expression and Localization of Synucleins in Fish 
Syn expression has been studied in lamprey (P. marinus), electric ray (T. californica), zebrafish  
(D. rerio), carp (Cyprinus carpio) and fugu (T. rupribes). 
As stated above, information on syn expression first came from Maroteaux and coworker’s studies 
in T. californica. These authors identified the first syn sequence, which is now considered a γ-syn 
isoform [2,10]. Both gene and protein expression of Torpedo syn are restricted to the CNS with most 
abundant transcripts in the electric lobe followed by the spinal cord and the brain. In the electric organ 
syn proteins were only detected without their mRNA transcripts. This is consistent with the fact that 
syns are synthesized in neuronal cell bodies and axonally transported to nerve terminals. The 
subcellular localization of syn proteins was analyzed in electromotor neurons by immunohistochemistry at 
LM (light microscopy) and TEM (transmission electron microscopy) level and results showed that syn 
is present in presynaptic terminals and in cell nuclei where labeling was intense along the inner nuclear 
membranes and diminished toward the center of the nuclei. 
The expression of the four syn isoforms was analyzed in the fugu T. rupribes by Western blot using 
specific antibodies [61]. The semiquantitative analysis showed that α-, β- and γ1-syn are expressed at 
similar high levels in brain homogenates, whereas γ2-syn is expressed at lower levels. 
The three syns showed different levels of gene expression and regulation in the lamprey brain [66]. 
Higher amounts of γ-syn DY transcripts were detected in comparison to γ-syn FD and syn-3 
transcripts. Moreover, the three genes were expressed to different levels in different neuronal 
populations. High γ-syn DY expression was detected in giant reticulospinal (RS) neurons, while γ-syn 
FD and syn-3 showed the highest expression levels in the facial motor nucleus (VIIn) (Figure 2A). 
Interestingly, the three genes were differently regulated in axotomized neurons. Indeed, mRNA levels 
for γ-syn DY strongly decreased in injured neurons while no changes were detected for γ-syn FD and 
syn-3 mRNA levels. Cellular distribution of syn proteins was analyzed by immunofluorescence using a 
pan-syn polyclonal antibody able to detect all three syn isoforms. Results showed that lamprey syns 
are located in cell soma of control RS neurons but are also associated to nuclear and plasma 
membranes of axotomized neurons.
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Figure 2. Synuclein expression in lamprey, zebrafish and carp. (A) Schematic 
representation of syn gene expression in a parasagittal section of the adult lamprey brain 
drawn on the base of data published by [66]; (B) Temporal expression pattern of syn genes 
in zebrafish embryo as described by [70]. The expression of sncb was initially detected in 
the trigeminal placode (a), then it expanded to ventral diencephalon, olfactory placode, 
ventral tegmentum, spinal cord neurons (b) and finally it was restricted to the brain and 
retina (c). The expression of sncga was initially detected in spinal cord neurons and pineal 
gland (d), afterwards it was detected in hindbrain neurons (e), then it was much prominent 
in brain and cranial ganglia (f) and finally sncga expression was restricted to the brain and 
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retina (g). The expression of sncgb showed a different spatio-temporal distribution limited 
only to notochord (h); (C) Spatial expression pattern of syn genes in zebrafish embryo at 
24 hpf (h post fertilization) as described by [71]. The sncgb expression is restricted to the 
notochord, whereas sncb and sncga are expressed in the brain and spinal cord. Red, blue 
and green dots indicate sncb, sncga and sncgb expression, respectively; (D): Syn genes 
expression pattern in the main organs of adult zebrafish on the base of results of [72]. Red, 
blue and green dots indicate sncb, sncga and sncgb expression, respectively;  
(E): Schematic representation of sncb and sncga expression pattern in a parasagittal section 
of the adult zebrafish brain drawn on the base of data published by [71]. Red, blue and 
green dots indicate sncb, sncga and sncgb expression, respectively. The different 
expression pattern of the two syn genes is well evident: sncb showed a most rostral 
expression whereas sncga showed a more intensive expression in posterior brain regions; 
(F): Schematic representation of the expression of α-syn-like proteins in a parasagittal 
section of the adult carp brain drawn on the base of data published in [73]. Large black 
dots indicate 3D5 immunoreactive perikarya and small black dots indicate 3D5 
immunoreactive varicose fibers. 
More detailed information are available for zebrafish in which the expression of syn genes was 
analyzed in both embryos and adult animals [70–72].  
Early expression of sncb, sncga and sncgb, showed different spatio-temporal patterns in zebrafish 
embryos analyzed by whole-mount in situ hybridization [70]. The gene sncb (β-syn) was first 
expressed from the eight-somite stage to three days post fertilization (dpf) [70]. Its expression was 
initially restricted to the trigeminal placode but then extended to the olfactory placode, ventral 
diencephalon, ventral tegmentum and spinal cord neurons by the 20-somite stage. At later stages, sncb 
expression became restricted to the brain and the retina where it was detected from 45 h post 
fertilization (hpf) up to 3 dpf. The expression of sncga (γ-synA or γ1) was not detected at early stages 
but initiated at 26 hpf in the nervous system beginning from spinal cord neurons and the pineal gland. 
It was then detected in hindbrain segmental neurons (38 hpf) becoming much more prominent in brain 
and cranial ganglia at two dpf. Similarly to sncb, the expression of sncga was restricted to the brain 
and the retina by three dpf. These data demonstrated that sncb and sncga are expressed in central and 
peripheral neurons irrespective of their different embryonal origin (neural plate versus placodes or 
neural crest). Very different spatio-temporal patterns were shown for sncgb (γ-synB or γ2) whose 
expression initiated earlier than sncga, was restricted to the notochord and was only detectable in the 
short time from the 12-somite stage to two dpf. Later on, sncgb expression diminished no more being 
detectable beyond 2 dpf. The spatio-temporal expression pattern of syn genes in zebrafish embryos is 
represented in Figure 2B,C.  
Temporal and spatial expression profiles of syn genes were also confirmed in zebrafish embryos by 
RT-PCR which also provided a semiquantitative evaluation of the expressional patterns [72]. Both 
sncb and sncgb expression were detected at early developmental stages (4 hpf) with sncb much more 
abundant than sncgb transcripts. Expression levels of sncb were intense at all developmental stages 
analyzed (4 hpf to 5 dpf). In contrast, levels of sncgb mRNAs were generally lower than those of sncb 
and further decreased by four dpf. The expression of sncga initiated later than sncb and sncgb (by one 
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dpf) but its transcript level was similar to sncb at five dpf. The expression pattern of sngca was also 
analyzed in a transgenic stable zebrafish line. This line was obtained by microinjection into zygotes of 
a gene construct containing the GFP reporter gene under the control of the sngca promoter [72]. 
Expression profiles of sngca were obtained in transgenic embryos and larvae by whole-mount in situ 
hybridization, immunostaining, and high-resolution confocal microscopy. This analysis reported that 
sncga is expressed in both CNS and PNS of embryos and larvae. In 48 hpf embryos, GFP expression 
was found in retina, lens, hindbrain and spinal cord, but also in trigeminal and posterior lateral line 
ganglia. Similarly, at three dpf, the expression of sngca was detected in the diencephalon (habenula), 
eyes, midbrain, hindbrain, but also in trigeminal, vagal, and posterior lateral line ganglia. These results 
substantially confirmed the distribution of sncga described by Sun and Gitler [70] except for the 
positive staining described in the epiphysis that, according to the finest detection made by  
Chen et al. [72], is rather localized in the habenula. 
Regional expression of syn genes is maintained in adult zebrafish as demonstrated by RT-PCR [72]. 
Thus, both sncb and sncga transcripts were particularly abundant in brain and eye, whereas sncgb was 
moderately expressed in brain and several non-nervous tissues, as testis and kidney. 
The expression of syn genes was further reinvestigated in zebrafish brain and spinal cord from early 
embryo to adult stage by Northern blot and RNA in situ hybridization [71]. Northern blot analysis 
confirmed that both sncb and sncg1 (sncga) are expressed in the adult CNS whereas sncg2 (sncgb) 
transcript levels were too low to be identified. On confirming previous results, this study showed that 
the expression pattern of syn genes in embryos was similar to that found in adults with sncb and sncg1 
mainly expressed in the CNS and sncg2 expressed in the notochord. In adult zebrafish, sncb and sncg1 
transcripts were both found in neurons throughout the brain and the spinal cord but their expression 
levels were often opposite in anteroposterior direction. Indeed, high levels of sncb transcripts were 
detected in the olfactory bulb and dorsal telencephalon where sncg1 is expressed at low levels. 
Conversely, sncg1 transcripts were abundant in the dorsal diencephalon (habenula) and hindbrain 
where sncb expression is moderate. By comparing zebrafish with lamprey it emerges that γ-syn 
expression in the reticular formation is conserved in the two lineages. Expression profiles of syn genes 
in the adult lamprey and zebrafish are depicted in Figure 2A,E. 
At cellular level, sncb and sncg1 were generally expressed by separate cell populations even in 
those brain regions in which their expression was overlapped. For example, sncb was mostly expressed 
in granules and sncga in Purkinje cell layer of the cerebellum. However, major catecholaminergic cell 
groups expressed both sncb and sncg1 as demonstrated by double labeling ISH/IHC experiments.  
Further data in Cyprinus carpio was recently reported by our group [73]. We studied the 
distribution of a putative endogenous α-syn in the brain and spinal cord of the adult carp by providing 
the first neuroanatomical map of the α-syn distribution in the teleost CNS. The expression of α-syn 
was analyzed by Western blot and immunohistochemistry using a non commercial monoclonal 
antibody (3D5) developed against the C-terminal epitope (DMPVDPD) of human α-syn. This epitope 
is perfectly conserved in the carp α-syn. In brain and spinal cord homogenates, 3D5 antibody 
immunolabeled carp α-syn as a protein band at about 17 kDa. Western blot analysis showed that this 
protein is expressed to different levels in all brain regions and the spinal cord. The highest expression 
was detected in the midbrain tectum, followed by cerebellum and diencephalon whereas lower 
expression levels were found in brainstem, spinal cord and telencephalon [73]. 
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The same 3D5 antibody was used for the immunohistochemical identification of α-syn expressing 
neuronal populations in the carp CNS. Positive neurons were not identified in the telencephalon but 
neurons expressing α-syn were localized in prethalamus, hypothalamus, synencephalon, cerebellum, 
brainstem and spinal cord (Figure 2F). Intracellular distribution was almost ubiquitous, since α-syn 
was localized in perikarya, dendrites, axons and axon terminals, except for the cell nucleus. This 
aspect differentiated subcellular distribution of carp α-syn from that of Torpedo syn, which was 
specifically localized to the nucleus and presynaptic terminals. This may represent a true difference 
between α-(carp) and γ-syn (electric ray) intracellular distribution. Moreover, since 3D5 is able to 
specifically recognize nuclear α-syn in mammalian neurons [74], this result suggests that α-syn is 
present at very low levels in the nucleus of carp neurons. Further studies on the distribution of the 
three syns in fishes are necessary to elucidate this point. 
Our results demonstrated that carp α-syn is expressed by cholinergic ChAT immunoreactive 
neurons throughout the brain and the spinal cord. Differently, few subpopulations of monoaminergic 
neurons showed evidence of colocalization 3D5/TH or 3D5/5HT. This distribution markedly differs 
from expression profiles of syn genes in zebrafish [71]. However, it must be pointed out that cellular 
distribution of α-syn might be different from that of β and γ isoforms expressed in zebrafish. No data 
are yet available on cellular distribution of β- and γ-syn proteins in other fish species. 
No labeling for α-syn was found in the carp striatum whereas presynaptic staining for α-syn is 
present in the caudate-putamen and substantia nigra of mouse [74]. As reported above, both sncb and 
sncg1 are expressed in dopaminergic neurons of zebrafish that innervate brain structures corresponding 
to the teleostean striatum. Differences between zebrafish and carp need to be clarified by in situ 
hybridization and immunohistochemical studies analyzing the expression profiles of the three syns in 
the carp. 
4. Functions of Fish Synucleins 
Few studies addressed the issue of biochemical and physiological functions of syn proteins in 
fishes. Interestingly, in vitro experiments in fugu demonstrated that fish syns, as the mammalian 
isoforms, are lipid-binding proteins able to assembly themselves into filaments [61]. These 
biochemical properties have strong relevance in both physiological and pathological events, as they are 
linked to vesicle targeting of syn proteins and the formation of protein inclusions respectively. All of 
the four syns exhibited liposome-binding activity but α-syn had a greater affinity to liposomes 
compared with its human counterpart. Alpha-, γ1- and γ2-syn proteins were all able to assembly 
themselves into filaments at a speed eight times higher than that of mammalian isoforms. Differently, 
fugu β-syn failed to assembly in bulk as the human β-isoform. 
Larval movements were analyzed in zebrafish treated with morpholino to inhibit sncb and/or 
sncg1demonstrating that β- and γ1-syn are required for normal motor activity [71]. 
The expression of both genes is also necessary for establishment of normal dopamine levels. Thus, 
it was suggested that β- and γ1-syn expressed in dopaminergic neurons of zebrafish may regulate 
dopamine release from which normal striatal dopamine levels and movement regulation depends. A 
similar regulation by dopaminergic circuits is known in mammals. Tracer studies in zebrafish sustain 
this suggestion having shown that dopaminergic neurons in the posterior tuberculum give rise to 
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ascending projections to the dorsal nucleus of the ventral telencephalon, which is considered the 
teleostean striatum [75]. 
Interestingly, in the morpholino-treated zebrafish larvae, the exogenous expression of human α-syn 
was able to prevent the decrease in motor activity and the reduction in number of dopamine neurons. 
Research in zebrafish thus suggests the functional redundancy between syn isoforms, even from 
different species. This supports the functional conservation of syn proteins in vertebrates and suggests 
that β- and γ1-syn are required for spontaneous movements and dopaminergic functions playing 
similar roles to those established for α-syn in humans. Nonetheless, functional properties of α-syn 
orthologs remain to be investigated in fishes. 
5. Conclusions 
Pathological, biochemical and genetic evidence suggest that human α-syn plays a crucial role in the 
pathogenesis of Parkinson’s disease (PD), dementia with Lewy bodies (DLB), Multiple System 
Atrophy (MSA) and tumors [29,76–78]. Nonetheless, the biological activity of α-syn and its precise 
role in neurodegeneration remain poorly understood. Fish have played a crucial role in this field since 
the first discovery of α-syn sequence in the electric ray T. californica [2]. The subsequent discovery of  
α- β- and γ-syns in mammals and their involvement in diseases focused further studies to mammalian 
models with much less interest in fish syns. 
Available data highlight the species variability in the number of syn genes in fishes. Studies in  
fugu [61] and zebrafish [71] demonstrated the presence of four syn genes (coding α-, β-, γ1 and γ2) 
whereas only three genes (coding for β-, γ1 and γ2) are present in the zebrafish genome. Additional 
sequences for α-, β- and γ-syns have also been annotated in the NCBI database.  
Sequence data on fish syns are still limited and need to be biologically verified. However the 
cladogram of deduced amino acid sequences highlights the degree of identity between β-syn sequences 
in fish, human and rat. By contrast, only some α- and γ-syns clustered together with the mammalian 
counterparts. The remaining sequences were distributed in more distant clusters composed of different 
syn isoforms. This comparative analysis suggests that the majority of sequences first classified as X1, 
X2 or X3 α-syn or generically classified as “syn” or “syn-like” have a greater similarity to fish and 
mammalian γ-syn rather than to α- and β-syn; however exceptions are present. On the whole, these 
data suggest that the current syn nomenclature is still ambiguous and further studies are necessary to 
correctly classify fish syn sequences. 
Experimental data indicated that α- (carp), β- and γ1-syn (zebrafish) are expressed in the nervous 
system whereas γ2 isoform (zebrafish, fugu) is moderately expressed in the brain and also in non 
nervous tissues. Moreover, even in the actual panorama of partial and fragmentary information, 
available data indicated different spatiotemporal patterns of expression for the different syn isoforms 
in both embryos and adult fish tissues. 
Results in zebrafish and carp indicate that different syn isoforms may be expressed in separate, 
neurochemically different neuronal populations. In addition, intracellular syn distribution may differ 
with regard to nuclear localization. Indeed, nuclear localization was described for Torpedo (classified 
as γ-syn) and lamprey syns (classified as γ-syn DY, γ-syn FD and syn-3) but not in carp and  
zebrafish neurons. 
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In conclusion, data available on fish syns demonstrate a good level of sequence similarity with 
mammalian isoforms, the preservation of biochemical properties related to the pathogenesis of human 
neurodegenerative diseases and the close relationship among syns, dopamine and motor activity. 
Overall, this suggests that fish can be useful models for studying molecular mechanisms involved  
in synucleinopathies. 
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